Lobbying client

CARA THERAPEUTICS

biotechnology company

Filings
26
Filed by
1
Reported in-house
—
Reported by firms
$236,750

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2018 to 2024

Filings

26 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2024
LESTER HEALTH LAW PLLC — reported
2nd Quarter - Report
2nd Quarter 2024
LESTER HEALTH LAW PLLC — reported
1st Quarter - Report
1st Quarter 2024
LESTER HEALTH LAW PLLC — reported
4th Quarter - Report
4th Quarter 2023
LESTER HEALTH LAW PLLC $20,000 reported
3rd Quarter - Report
3rd Quarter 2023
LESTER HEALTH LAW PLLC $20,000 reported
2nd Quarter - Report
2nd Quarter 2023
LESTER HEALTH LAW PLLC $10,000 reported
1st Quarter - Report
1st Quarter 2023
LESTER HEALTH LAW PLLC $10,000 reported
4th Quarter - Report
4th Quarter 2022
LESTER HEALTH LAW PLLC — reported
3rd Quarter - Report
3rd Quarter 2022
LESTER HEALTH LAW PLLC — reported
2nd Quarter - Report
2nd Quarter 2022
LESTER HEALTH LAW PLLC $12,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
LESTER HEALTH LAW PLLC 25 $236,750

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medicare/Medicaid MMM 26

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 1971 117th 4
H.R. 4065 117th 4
H.R. 5027 118th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.